Synapse - Nancy Sklarin

Results (46)

← Previous 1 2 3 4 5 Next →

Phase II study of paclitaxel and dasatinib in metastatic breast cancer

Journal Article

Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
Clinical Breast Cancer (2018)

Fulltext@MSK | Save

Patient safety may be improved using a dose calculating-and-rounding electronic chemotherapy order entry and verification system with clinical decision support system (CDSS) features in the pediatric setting

Meeting Abstract

Gilheeney, S.; Ackerman, J.; De Luca, J.; Robinson, D.; Muller, R.; Sklarin, N.
Neuro-Oncology (2016)

Fulltext@MSK | Save

Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia

Journal Article

Belum, V. R.; Silva, G. D.; Laloni, M. T.; Ciccolini, K.; Goldfarb, S. B.; Norton, L.; Sklarin, N. T.; Lacouture, M. E.
Breast Cancer Research and Treatment (2016)

Fulltext@MSK | Save

Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result

Meeting Abstract

Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)

Meeting Abstract

Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer

Meeting Abstract

Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
Cancer Research (2013)

Fulltext@MSK | Save

Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer

Meeting Abstract

Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; more...
Cancer Research (2012)

Fulltext@MSK | Save

Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer

Journal Article

Murphy, C. G.; Mallam, D.; Stein, S.; Patil, S.; Howard, J.; Sklarin, N.; Hudis, C. A.; Gemignani, M. L.; Seidman, A. D.
Cancer (2012)

Fulltext@MSK | Save

Incidence of hypersensitivity reactions (HSRs) to albumin-bound paclitaxel (ABI) in patients (pts) with a history of HSR to cremophor-based paclitaxel (P)